February 22, 2016
With significant technology advances in ECG recording through the years, the need to expand on traditional monitoring baselines-and include new variables such as time when designing clinical trial protocols-is important.
September 22, 2014
The US FDA, in open meetings, stated the Thorough QT trial "must" be replaced.
February 01, 2013
The sponsor of a recent Phase II global study, conducted at more than 50 sites, invested in a centralized digital pathology core lab to ensure a homogenous and representative study population.
January 10, 2013
January 01, 2012
The responsibilities regarding CV safety for drug developers are constantly evolving.
November 01, 2010
Centralized approach for Phase III studies enhances the quality and integrity of collected data.